Page 15 - 南京医科大学自然版
P. 15
第45卷第7期 南京医科大学学报(自然科学版)
2025年7月 Journal of Nanjing Medical University(Natural Sciences) ·913 ·
·专题研究:乳腺癌·
溶瘤病毒在乳腺癌治疗中的研究进展
陈宗浩 ,吴 穹 ,陈 磊 1,2*
2
1,2
南京医科大学姑苏学院,江苏 苏州 215000;南京医科大学附属苏州医院介入血管科,江苏 苏州 215000
1 2.
[摘 要] 乳腺癌(breast cancer,BC)作为全球女性最普遍的恶性肿瘤,已成为全球重大公共卫生问题。虽然早期诊断和治疗
技术有所提升,但治疗效果仍不尽人意。BC作为一种具有高度异质性和多种分子分型的恶性肿瘤,其复杂的生物学特性为治
疗带来了极大挑战。传统的化疗和免疫疗法存在精确度不足、不良反应严重以及容易产生耐药性等问题,因此迫切需要开发
新的治疗方案。溶瘤病毒(oncolytic virus,OV)作为一种创新性癌症治疗手段,其独特之处在于能够精确识别并攻击癌细胞,
同时激活机体的免疫系统以对抗癌症。目前,已有多种OV被应用于癌症治疗,如单纯疱疹病毒(herpes simplex virus,HSV)、
新城疫病毒(newcastle disease virus,NDV)、水疱口炎病毒(vesicular stomatitis virus,VSV)、麻疹病毒(measles virus,MV)、腺病毒
(adenovirus,AdV)和牛痘病毒(vaccinia virus,VV)等。此外,新型OV的构建和与传统疗法的联合研究也取得了显著进展。文
章综述了近5年来常见OV在BC治疗领域的研究进展,肯定了OV的巨大潜力。
[关键词] 溶瘤病毒;乳腺癌;联合治疗
[中图分类号] R737.9 [文献标志码] A [文章编号] 1007⁃4368(2025)07⁃913⁃12
doi:10.7655/NYDXBNSN250062
Research progress of oncolytic viruses in breast cancer treatment
1,2
2
CHEN Zonghao ,WU Qiong ,CHEN Lei 1,2*
1 Gusu School,Nanjing Medical University,Suzhou 215000;Department of Interventional Vascular Surgery,Suzhou
2
Hospital Affiliated to Nanjing Medical University,Suzhou 215000,China
[Abstract] Breast cancer(BC),as the most common malignant tumor among women globally,has become a significant public health
issue worldwide. Although improvements in early diagnosis and treatment technologies,the therapeutic outcomes remain less than
satisfactory. BC,characterized by its high heterogeneity and multiple molecular subtypes,poses a considerable challenge to treatment
due to its complex biological properties. Traditional chemotherapy and immunotherapy suffer from issues such as insufficient precision,
severe side effects,and the tendency to develop drug resistance,thus highlighting the urgent need to develop new therapeutic
strategies. Oncolytic viruses(OV)have emerged as an innovative cancer treatment method. Their uniqueness lies in the ability to
precisely identify and attack cancer cells while simultaneously activating the body’s immune system to combat cancer. Currently,
various OVs have been applied in cancer therapy,including herpes simplex virus(HSV),newcastle disease virus(NDV),vesicular
stomatitis virus(VSV),measles virus(MV),adenovirus(AdV),and vaccinia virus(VV). Moreover,significant progress has been made
in the construction of novel OV and the combination with traditional therapies. This article reviews the research progress of common
OV in the field of BC treatment over the past five years,thus affirming the great potential of OV.
[Key words] oncolytic viruses;breast cancer;combined therapy
[J Nanjing Med Univ,2025,45(07):913⁃924]
[2]
乳腺癌(breast cancer,BC)是女性发病率最高 女性BC的发病率占全球癌症总数的11.6% 。BC的
的恶性肿瘤 ,根据国际癌症研究机构的最新结果, 分子亚型主要包括Luminal A型、Luminal B型、人表
[1]
皮生长因子受体⁃2(human epidermal growth factor 2,
[基金项目] 江苏省卫生健康委医学科研项目(H2023009)
∗ HER ⁃ 2)阳 性 型 和 三 阴 性 乳 腺 癌(triple ⁃ negative
通信作者(Corresponding author),E⁃mail:chenlei⁃dennis@njmu.
edu.cn(ORCID:0000⁃0002⁃1048⁃0234) breast cancer,TNBC),这些亚型在发病率、生物学特

